For more VICC news, visit their website »
Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.
Theresa Sberna, MPH, has been named director of Strategy and Analytics for Vanderbilt-Ingram Cancer Center (VICC). Sberna, who previously served as associate director, has been with the Cancer Center for five years.
Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.
Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients.
The Vanderbilt–Incyte Research Alliance announces a funding opportunity to support faculty in the areas of applied and translational research.
Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.